RCKT · Forms 3, 4, 5
Insider trades at ROCKET PHARMACEUTICALS, INC.
4 insiders sold $432K of ROCKET PHARMACEUTICALS, INC. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for ROCKET PHARMACEUTICALS, INC. (RCKT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Martin Wilson | General Counsel | Sell | 75,364 | $3.40 | $256K | Form 4 | |
| Martin Wilson | General Counsel | Sell | 631 | $3.38 | $2K | Form 4 | |
| Gaurav Shah | CEO | Sell | 2,293 | $3.38 | $8K | Form 4 | |
| Gaurav Shah | CEO | Sell | 2,837 | $3.38 | $10K | Form 4 | |
| Martin Wilson | General Counsel | Sell | 3,493 | $3.38 | $12K | Form 4 | |
| Christopher James Stevens | Chief Operating Officer | Sell | 36,658 | $3.50 | $128K | Form 4 | |
| Sarbani Chaudhuri | See Remarks | Sell | 4,701 | $3.50 | $16K | Form 4 | |
| Christopher James Stevens | Chief Operating Officer | Award | 73,313 | Form 4 | |||
| David P Southwell | Director | Other | 150,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.